Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Change in Young Mania Rating Scale (YMRS) total score from baseline to the end of treatment.
Change from baseline to the end of treatment in Clinical Global Impression-Severity of Illness (CGI-S) scale, Global Assessment Scale (GAS), and Positive and Negative Syndrome Scale (PANSS) total score; incidence of adverse events throughout study.
18 Years and older (Adult, Senior)
November 22, 2005
January 14, 2011
† Study has passed its completion date and status has not been verified in more than two years.